Skip to main content

Thermo Fisher Scientific Inc.

corporate_fare Company Profile

Thermo Fisher Scientific Inc.

TMO·NYSE·Industrial Applications And Services·CIK 0000097745

Thermo Fisher Scientific Inc. is the world leader in serving science, aiming to enable customers to make the world healthier, cleaner, and safer. The company serves customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental, industrial, research and development, quality, and process control settings. Thermo Fisher delivers innovative technologies, purchasing convenience, and pharmaceutical services through brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. The company expands its capabilities through organic investments in research and development, capacity, and acquisitions. Thermo Fisher reports its business in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments, and consumables for biological and medical research, drug and vaccine discovery and production, and disease diagnosis. These products and services are used by customers in pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. This segment includes three primary businesses: biosciences, genetic sciences, and bioproduction. The biosciences business offers reagents, instruments, and consumables for biological and medical research in areas like molecular biology and protein biology, new drug and vaccine discovery, and disease diagnosis.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for TMO at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Thermo Fisher Scientific Announces COO and EVP Departures, Promotes New COO and Expands CEO Role

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$44.56B
Net Income
$6.7B
Diluted EPS
$17.74
Op. Cash Flow
$7.82B
Free Cash Flow
$6.29B
Operating Income
$7.75B
Cash & Equivalents
$9.85B
Total Debt
$42.7B
Debt / Equity
0.80×
Net Margin
15.0%
Shares Outstanding
377M sh
Source: 10-K · filed 2026-02-26 · accession 0000097745-26-000018
$673.5 +0.59% today
52-week range · as of 2026-10-30 $435.27 – $711.85
Market cap
$248.08B
Volume
2.4M (1.1× avg)
3-mo avg 2.2M
Live data · 2026-11-22 12:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TMO - Filings & News (Page 2)

TMO
Jan 12, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $618.86
Real-time Price: $673.50 info
Change: +$54.64 (+9%) info
Market Cap: $248.075B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets